Get started
Author

Linda-Marie Ustaris Lavenburg

Observed names: LINDA-MARIE U. LAVENBURG, Linda-Marie Lavenburg, Linda-Marie U. Lavenburg, LindaMarie U. Lavenburg, Linda‐Marie Lavenburg
ORCID: 0000-0001-8813-7017
Observed ORCID: 0000-0001-8813-7017
OpenAlex ID: A5015553529
Electronic Health Record Population Health Management for Chronic Kidney Disease Care
2024 · Manisha Jhamb, Melanie R. Weltman, et al. · JAMA Internal Medicine · 43
PDF
ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases
2024 · T. Alp Ikizler, Holly J. Kramer, et al. · Journal of the American Society of Nephrology · 41
Trends, Social Context, and Transplant Implications of Obesity Among Incident Dialysis Patients in the United States
2022 · Linda-Marie U. Lavenburg, Yuna Kim, et al. · Transplantation · 22
Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity
2024 · Chethan M. Puttarajappa, Kenneth J. Smith, et al. · American Journal of Transplantation · 18
PDF
Population Health Management and Guideline-Concordant Care in CKD
2024 · Melanie R. Weltman, Linda-Marie U. Lavenburg, et al. · Journal of the American Society of Nephrology · 8
A Comprehensive Exercise (COMEX) Intervention to Optimize Exercise Participation for Improving Patient-Centered Outcomes and Physical Functioning in Patients Receiving Hemodialysis: Development and Pilot Testing
2023 · Manisha Jhamb, Susan M. Devaraj, et al. · Kidney Medicine · 8
PDF
The 10-Year Effects of Intensive Lifestyle Intervention on Kidney Outcomes
2024 · Linda-Marie U. Lavenburg, Douglas E. Schaubel, et al. · Kidney Medicine · 7
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized Trial
2025 · Melanie R. Weltman, Zhuoheng Han, et al. · Kidney Medicine · 5
PDF
Obesity in CKD: Core Curriculum 2026
2026 · Holly J. Kramer, Linda-Marie Lavenburg, et al. · American Journal of Kidney Diseases · 4
Patient Perceptions of a Population Health Management Program to Improve Kidney Care: Optimizing care in CKD
2025 · Linda-Marie U. Lavenburg, Susan M. Devaraj, et al. · Kidney Medicine · 3
PDF
Using Machine Learning to Predict Medication Therapy Problems among Patients with Chronic Kidney Disease
2025 · Alaa A. Alghwiri, Melanie R. Weltman, et al. · American Journal of Nephrology · 2
Population Health Management for Improving Kidney Health Outcomes
2025 · Manisha Jhamb, Jane O. Schell, et al. · American Journal of Kidney Diseases · 2
PDF
Clearing the air: a review of the effects of air pollution on dialysis outcomes
2024 · Annika Spencer, Linda-Marie Lavenburg, et al. · Current Opinion in Nephrology & Hypertension · 2
PDF
Primary Care Provider Perceptions of a Population Health Management Program to Improve Kidney Care: A Mixed Methods Study
2026 · Melanie R. Weltman, Linda-Marie U. Lavenburg, et al. · Journal of General Internal Medicine · 1
PDF
Factors Associated With Weight Management Referral Acceptance and Uptake in Kidney Transplant Candidates
2026 · Linda‐Marie Lavenburg, Harry Morford, et al. · Clinical Transplantation
PDF
Barriers to Use of Cardio-Kidney Protective Medications in Chronic Kidney Disease: Results of a Nephrology Provider Survey
2026 · Melanie R. Weltman, Linda-Marie U. Lavenburg, et al. · Kidney Medicine
Wcn26-8305 Predictors of Cardiovascular-kidney-metabolic Syndrome Progression and Gaps in Care Among Patients With Chronic Kidney Disease
2026 · Melanie Weltman, Zhuoheng Han, et al. · Kidney International Reports
Abstract TH942: A Human-Centered Design Approach to Develop 'The Health Integrated Nutrition and Kidney Wellness' Intervention with Community, Health System, and Patient Partners
2026 · Linda-Marie Lavenburg, Manisha Jhamb · Circulation
Patient Perspectives on Ways to Improve Participation and Engagement with Kidney Nutrition Education
2025 · Linda-Marie Ustaris Lavenburg, Lane Alexander, et al. · Journal of the American Society of Nephrology
Factors Associated With Initiation of Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP Trial
2025 · Linda-Marie U. Lavenburg, Mitra Mosslemi, et al. · Diabetes Spectrum
PDF
Factors Associated With Initiation of Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP Trial
2025 · Linda-Marie U. Lavenburg, Mitra Mosslemi, et al.
PDF
Factors Associated With Initiation of Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP Trial
2025 · Linda-Marie U. Lavenburg, Mitra Mosslemi, et al.
Characterizing obesity: A qualitative study
2025 · Tim Bober, Flor Cameron, et al. · Obesity Pillars
Barriers to Obesity Management in Kidney Transplant Candidates
2024 · Linda-Marie Ustaris Lavenburg, Harry Morford, et al. · Journal of the American Society of Nephrology
Prediction of Medication Therapy Problems in Patients with Moderate- to High-Risk CKD
2024 · Melanie R. Weltman, Alaa A. Alghwiri, et al. · Journal of the American Society of Nephrology
Works count: 36
Citation count: 166
H-index: 7
I10-index: 4
Year
Topic
Type